this was a press release from last yr, about a study of the quadruple test. hth
Results from five-year study show ?Quadruple Test? most effective at detecting Down?s Syndrome
Results from five years? research of antenatal screening methods for Down?s syndrome, involving close to 50,000 women, are published in The Lancet this week (8 March 2003).
Led by Professor Nicholas Wald of the Wolfson Institute of Preventive Medicine at Barts and the London, Queen Mary?s School of Medicine and Dentistry, the project involved screening 46,139 pregnant women for Down?s syndrome babies in 14 hospitals in the South East from 1996 to 2001. Results show that the quadruple test is far more effective than screening based on maternal age alone. The quadruple test is also substantially better at detecting Down?s syndrome than the double test, and moderately better than the triple test. This test is used throughout the world but it is not yet the standard test in the UK National Health Service.
Professor Wald said: "These results confirm the value of early second trimester serum screening over screening by use of maternal age alone, in contradiction to recent opinion, and lend support to the decision of the UK government to offer serum screening to all pregnant women. The study also confirms that in the second trimester the quadruple test is sufficiently more effective than the double or triple tests that it should be regarded as the test of choice at this time of pregnancy."
Screening for Down?s syndrome is widely practised throughout the world early in the second trimester (weeks 14 ? 22) of pregnancy. A number of tests are used to calculate the risk of Down?s syndrome, including the double test, triple test and quadruple test, which measure two, three and four ?markers? in the maternal serum, combined with the mothers age when she is due to give birth.
The women in this study were screened during the second trimester of pregnancy using the quadruple test which measures four markers found in the maternal serum ? alphafetoprotein, unconjugated oestriol, human chorionic gonadotropin and inhibin-A.
The results showed that the detection rate with the quadruple test was 81% (71 of 88 Down?s syndrome pregnancies were detected) and the false-positive rate was 7% (of the 46,105 unaffected pregnancies, 3,200 falsely tested positive for Down?s syndrome).
The quadruple test was shown to be more reliable than using maternal age alone (i.e when the four blood markers were ignored and a maternal age of 35 years and over was the criteria for selecting women for a diagnosis test). Using maternal age alone only 51% of cases were detected and the false-positive rate was 14%. The quadruple test was also better than screening which relied on the measurement of two or three markers in the maternal serum instead of four.